Acute lung injury (ALI) can be a devastating disorder secondary to pneumonia or sepsis. Two hallmarks of ALI are (1) profound alveolar inflammation, and (2) defects in cellular oxygen extraction, both of which may have a mitochondrial basis. Although ALI subjects have mitochondrial defects, the molecular mechanisms by which impairment of these organelles trigger inflammation and disrupt oxygen consumption remain unclear. Here we discovered in preliminary studies that in ALI models there is a deficiency of a crucial cytoprotective, anti-inflammatory mitochondrial homeostat, Parkin, through its elimination by a relatively new E3 ligase protein, Fbxo7. By targeting the FP molecular signature present in Fbxo7, we designed and tested a novel small molecule inhibitor, BC1464, which stabilizes mitochondrial function and reduces inflammation in murine and human ALI models. Hence, in this application we will first elucidate how bacterial pathogens deplete Parkin through Fbxo7, thereby accentuating experimental ALI (Aim 1). We will specifically elucidate how Fbxo7 targets Parkin for its degradation using complementary in vitro and in vivo genetic models. Next, we will optimize the pharmacologic design and test a novel small molecule that exhibits distinct, and yet complementary anti-inflammatory and mitochondrial-protective properties in ALI models including an isolated human perfused lung system (Aim 2). These studies will provide a new pathobiologic model of lung injury that will serve as a platform for generating small molecule modulators that optimize cellular bioenergetics and limit inflammation in subjects with severe critical illness.

Public Health Relevance

Acute lung injury (ALI) is a major cause of death in the US and evidence suggests that patients die from overwhelming lack of ability to use oxygen coupled with inflammation, making people prone to severe lung injury. The oxygen defect may be due to damage to energy-producing mitochondria in cells. We have discovered a new model that may explain these abnormalities in ALI subjects that led us to develop a novel drug that reduces the oxygen defect and inflammation. This discovery fulfills an unmet need in ALI therapy.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
7R01HL096376-08
Application #
9829429
Study Section
Lung Injury, Repair, and Remodeling Study Section (LIRR)
Program Officer
Aggarwal, Neil Raj
Project Start
2010-02-01
Project End
2020-03-31
Budget Start
2019-02-10
Budget End
2019-03-31
Support Year
8
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Suber, Tomeka L; Nikolli, Ina; O'Brien, Michael E et al. (2018) FBXO17 promotes cell proliferation through activation of Akt in lung adenocarcinoma cells. Respir Res 19:206
Evankovich, John; Lear, Travis; Mckelvey, Alison et al. (2017) Receptor for advanced glycation end products is targeted by FBXO10 for ubiquitination and degradation. FASEB J 31:3894-3903
Weathington, Nathaniel M; Kanth, Shreya M; Gong, Qiaoke et al. (2017) IL-4 Induces IL17Rb Gene Transcription in Monocytic Cells with Coordinate Autocrine IL-25 Signaling. Am J Respir Cell Mol Biol 57:346-354
Suber, Tomeka; Wei, Jianxin; Jacko, Anastasia M et al. (2017) SCFFBXO17 E3 ligase modulates inflammation by regulating proteasomal degradation of glycogen synthase kinase-3? in lung epithelia. J Biol Chem 292:7452-7461
Han, SeungHye; Jerome, Jacob A; Gregory, Alyssa D et al. (2017) Cigarette smoke destabilizes NLRP3 protein by promoting its ubiquitination. Respir Res 18:2
Lendermon, Elizabeth A; Coon, Tiffany A; Bednash, Joseph S et al. (2017) Azithromycin decreases NALP3 mRNA stability in monocytes to limit inflammasome-dependent inflammation. Respir Res 18:131
Londino, James D; Gulick, Dexter L; Lear, Travis B et al. (2017) Post-translational modification of the interferon-gamma receptor alters its stability and signaling. Biochem J 474:3543-3557
Bednash, Joseph S; Weathington, Nathaniel; Londino, James et al. (2017) Targeting the deubiquitinase STAMBP inhibits NALP7 inflammasome activity. Nat Commun 8:15203
Zou, Chunbin; Synan, Matthew J; Li, Jin et al. (2016) LPS impairs oxygen utilization in epithelia by triggering degradation of the mitochondrial enzyme Alcat1. J Cell Sci 129:51-64
Liu, Yuan; Mallampalli, Rama K (2016) Small molecule therapeutics targeting F-box proteins in cancer. Semin Cancer Biol 36:105-19

Showing the most recent 10 out of 52 publications